Profile | GDS4284 / 219276_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3680.73 | 91 |
GSM687648 | Patient 402 control | 3768.56 | 91 |
GSM687653 | Patient 403 control | 4312.74 | 92 |
GSM687658 | Patient 404 control | 2934.21 | 88 |
GSM687663 | Patient 411 control | 2589.53 | 87 |
GSM687668 | Patient 422 control | 2815.93 | 88 |
GSM687673 | Patient 424 control | 3014.38 | 89 |
GSM687678 | Patient 425 control | 2414.96 | 86 |
GSM687683 | Patient 427 control | 2575.71 | 87 |
GSM687688 | Patient 428 control | 2614.56 | 87 |
GSM687695 | Patient 441 control | 1817.92 | 84 |
GSM687699 | Patient 443 control | 1925.12 | 84 |
GSM687704 | Patient 444 control | 2711.81 | 88 |
GSM687707 | Patient 448 control | 3550.77 | 91 |
GSM687712 | Patient 449 control | 3825.56 | 91 |
GSM687719 | Patient 450 control | 2691.62 | 88 |
GSM687724 | Patient 451 control | 3059.68 | 89 |
GSM687728 | Patient 452 control | 3004.07 | 89 |
GSM687646 | Patient 401 treated 24h | 3267.27 | 89 |
GSM687649 | Patient 402 treated 24h | 3873.45 | 91 |
GSM687665 | Patient 411 treated 24h | 2732.27 | 88 |
GSM687651 | Patient 402 treated 4 weeks | 2619.19 | 87 |
GSM687667 | Patient 411 treated 4 weeks | 3450.21 | 90 |
GSM687670 | Patient 422 treated 24h | 3048.69 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 3278.48 | 90 |
GSM687654 | Patient 403 treated 24h | 3524.24 | 90 |
GSM687675 | Patient 424 treated 24h | 3218.69 | 90 |
GSM687685 | Patient 427 treated 24h | 2170.85 | 85 |
GSM687656 | Patient 403 treated 4 weeks | 3639.99 | 90 |
GSM687677 | Patient 424 treated 4 weeks | 2583.17 | 87 |
GSM687687 | Patient 427 treated 4 weeks | 3014.91 | 89 |
GSM687692 | Patient 428 treated 4h | 2640.95 | 87 |
GSM687716 | Patient 449 treated 4h | 3186.34 | 89 |
GSM687722 | Patient 450 treated 4h | 2939.14 | 89 |
GSM687680 | Patient 425 treated 24h | 3048.66 | 89 |
GSM687690 | Patient 428 treated 24h | 3211.71 | 89 |
GSM687700 | Patient 443 treated 24h | 1792.63 | 83 |
GSM687705 | Patient 444 treated 24h | 2363.9 | 86 |
GSM687714 | Patient 449 treated 24h | 4165.21 | 92 |
GSM687721 | Patient 450 treated 24h | 2843.12 | 88 |
GSM687682 | Patient 425 treated 4 weeks | 2563.12 | 87 |
GSM687694 | Patient 428 treated 4 weeks | 2577.82 | 87 |
GSM687702 | Patient 443 treated 4 weeks | 2755.42 | 88 |
GSM687718 | Patient 449 treated 4 weeks | 3211.06 | 90 |
GSM687723 | Patient 450 treated 4 weeks | 3129.69 | 89 |
GSM687661 | Patient 404 treated 4h | 3284.86 | 90 |
GSM687710 | Patient 448 treated 4h | 3550.11 | 90 |
GSM687726 | Patient 451 treated 4h | 3152.16 | 89 |
GSM687730 | Patient 452 treated 4h | 1439.23 | 80 |
GSM687660 | Patient 404 treated 24h | 1783.51 | 84 |
GSM687697 | Patient 441 treated 24h | 1562.44 | 81 |
GSM687709 | Patient 448 treated 24h | 4106.99 | 92 |
GSM687725 | Patient 451 treated 24h | 2994.42 | 89 |
GSM687729 | Patient 452 treated 24h | 1539.81 | 82 |
GSM687727 | Patient 451 treated 4 weeks | 1890.68 | 83 |
GSM687731 | Patient 452 treated 4 weeks | 2599.18 | 87 |